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THE SYNTHESIS OF A PEPTOID FOR USE AS A NOVEL 
THERAPEUTIC IN THE TREATMENT OF SICKLE· CELL DISEASE 
Michael Chiodo and Brian Brennan* 
Chemistry Department, Illinois Wesleyan University 
Sickle cell disease is a disorder of the body's red blood cells, characterized by their sickled 
shape. The cause of this disease is a single mutation in the protein hemoglobin, a molecule 
serving as the primary means of oxygen transport within the body. In hypoxic conditions, this 
mutant hemoglobin is capable of binding to other hemoglobin molecules leading to the formation 
of long polymeric strands and leaving the resultant red blood cell with a crescent shape. My 
research is focused on designing a molecule that can bind to the mutant hemoglobin and thereby 
disrupt the formation of polymeric strands and the subsequent misformation of the cell. 
